The Libin Cardiovascular Institute is shaping the future of cardiovascular health with groundbreaking work in Women’s Cardiovascular Health and Precision Medicine. Our researchers, core labs and clinicians are transforming how discoveries improve patient care, while we train the next generation of cardiovascular leaders. None of this progress would be possible without the generous support of our philanthropic community, which drives innovation that saves and improves lives.
2025
Shaping the Future of Cardiovascular Health
Libin Life is published by the Libin Cardiovascular Institute. It is dedicated to sharing news and information about the Institute’s work in cardiovascular research, patient care, and education.
Acting Institute Director Dr. Robert Rose
Editor Dawn Smith
Contributors Dawn Smith, Dr. Robert Rose, Mia Sosiak
Design and Layout Stacey Brown
Printer WCD Calgary
Libin Cardiovascular Institute University of Calgary, Foothills Campus HMRB 72, 3310 Hospital Drive NW Calgary, Alberta T2N 4N1
Phone 403.210.6157 libin@ucalgary.ca libin.ucalgary.ca X @LibinInstitute
Facebook @LibinInstituteAB Instagram @LibinInstitute LinkedIn @LibinCardiovascularInstitute
Send comments and enquiries to libin@ucalgary.ca. Please request permission to reproduce any part of this publication. All rights reserved. © 2025 Libin Cardiovascular Institute.
About the Libin Cardiovascular Institute
The Libin Cardiovascular Institute is a joint entity of Alberta Health Services and the University of Calgary. Our members include physicians, clinicians and other health professionals, researchers and trainees.
CONTENTS
4
16
LIBIN INITIATIVES: Libin Precision Medicine Initiative Launches Enhanced Cardiac Care Program
FUNDING IN ACTION: Autonomic Lab Finding Real-World Solutions for Patients FUNDING IN ACTION: Seed Funding Sparks Top-Ranked Heart Research
18
6
LIBIN INITIATIVES: Women's Cardiovascular Health Initiative Bridging the Gap LIBIN INITIATIVES: P2 Initiative Exposing & Addressing Cardiovascular Health Inequities CLINICAL INNOVATION SPOTLIGHT: Amyloidosis Program of Calgary a National Leader MEET A RESEARCHER: Cracking the Genetic Code of Heart Conditions
8
20
CORE LAB SPOTLIGHT: Physiology Core Lab Fuels Cardiovascular Research
22 24
10 12
CORE LAB SPOTLIGHT: Core Pathology Lab Supporting Critical Research Projects TRAINING THE NEXT GENERATION: Trainee Organization Building Community
26
DONOR SPOTLIGHT: Honouring the Mozell Family 14
GET INVOLVED: Help us Shape the Future of Cardiovascular Health
About the cover The Libin Cardiovascular Institute is shaping the future of cardiovascular health with groundbreaking work in Women’s Cardiovascular Health and Precision Medicine. Our researchers, core labs and clinicians are transforming how discoveries improve patient care, while we train the next generation of cardiovascular leaders. None of this progress would be possible without the generous support of our philanthropic community, which drives innovation that saves and improves lives.
MESSAGE FROM THE DIRECTOR
A t the Libin Cardiovascular Institute, everything we do is grounded in a shared purpose: improving the lives of people affected by cardiovascular disease, not just through discovery, but also through real-world impact. This work begins with people. Our researchers, clinicians, trainees and staff are united by a shared passion: to improve the lives of those affected by or at risk of cardiovascular disease. Whether it’s through innovation at the bedside, discoveries in the lab or partnerships in the community, the spirit of collaboration and compassion runs through everything we do. As we look to the future, we’re embracing bold new opportunities. Advances in areas like precision medicine, women’s cardiovascular health and health equity are allowing us to rethink how care is delivered — making it People are at the Heart of the Libin Cardiovascular Institute
Dr. Robert Rose, acting director of the Libin Cardiovascular Institute
more personalized, more proactive and more inclusive. These aren’t just ideas; they are already shaping how we treat, prevent and understand cardiovascular disease. None of this progress would be possible without the generosity of our supporters. Philanthropy helps us do the essential research and innovation required to leverage large grants (see story on pages 18-19) and purchase critical equipment (see story on pages 16-17). Your support is critical in allowing us to recruit experts to support our trainees, the future leaders of cardiovascular care and research. It ultimately fuels innovation, empowering us to think bigger and reach farther. This edition of Libin Life magazine offers a glimpse into that journey. Within these pages, you’ll find stories of resilience, discovery and hope. You’ll meet the people who are making change happen, and see the difference that donors make possible. Thank you for being part of our story. Together, we are creating a healthier future for all.
Thank you for being part of our story " "
Dr. Robert Rose Acting Director Libin Cardiovascular Institute
2
LIBIN LIFE
MESSAGE FROM THE EDITOR
Shaping the Future of Cardiovascular Health Through Research & Education
By Dawn Smith, Editor
A t the Libin Cardiovascular Institute, our goal is clear: to improve and save lives through cutting-edge cardiovascular research, clinical care and education. Cardiovascular disease remains the leading cause of death worldwide, but we believe the future can be different. Research and education are at the core of everything we do. Our members—a multidisciplinary network of clinicians, scientists, educators and learners—are advancing the understanding, prevention and treatment of heart disease in ways that are making a tangible impact in Calgary and beyond. Whether it’s investigating the genetic roots of cardiovascular conditions, exploring the influence of sex and gender on heart health, or innovating new precision medicine diagnostic tools and therapies, our research efforts are focused on translating discovery into better outcomes for patients. We are equally committed to education: from training the next generation of scientists and clinician-researchers
to equipping today’s health professionals with the tools needed to integrate evidence-based innovations into practice. Through mentorship, interdisciplinary collaboration and hands-on learning, the Libin Institute is shaping the future of cardiovascular care. Our strategic initiatives, which are focused on precision medicine, women’s cardiovascular health, equity in cardiovascular health and clinical innovation, help us translate this research and education into real-world change. But we can’t impact the future without the generous support of our community. Your contributions help drive discoveries, train future leaders and transform care for patients and populations. We invite you to be part of the institute’s progress. Together, through research and education, we can build a future where fewer lives are lost to cardiovascular disease and every person has the opportunity for a healthier heart.
3
LIBIN LIFE
LIBIN INITIATIVES
Libin Precision Medicine Initiative Launches Enhanced Cardiac Care Program PULSE Clinic Program provides data resources for patient care By Dawn Smith
C algary cardiac patients will have the opportunity to participate in research while visiting local cardiac clinics at Alberta Health Services (AHS) facilities. The Libin Precision Medicine Initiative (LPMI) launched its PULSE Clinic Program earlier this year with the goal of advancing personalized cardiac care for Albertans. The program is being rolled out in phases in clinics around the city over the next 18 months. According to Dr. Rhys Beaudry, PhD, LPMI’s research manager, when patients visiting participating clinics get a reminder for their cardiac appointment, they receive a link to a voluntary short electronic questionnaire to capture their perspective on their health, symptoms and lifestyle— details not typically captured in regular health data. They can also complete the questionnaire while in clinic waiting rooms. Guided by the patient’s consent, information from the surveys is anonymized and combined with their medical record to allow the development and testing of personalized care tailored to each individual. As a partnership between AHS and the Libin Cardiovascular Institute, the PULSE Clinic Program was designed to enable patients to maintain control over how their health data is used to support innovation and improve care. Beaudry notes the PULSE Clinic Program is one of the largest patient-guided health-care initiatives to date in the province.
“By allowing patients to add their own perspectives to their health data and participate in innovative research, we hope to significantly improve patient outcomes over the next several years,” says Beaudry. Patients can participate by following the link in their appointment reminder, or during their clinic visit by scanning a QR code on their own device. They can also take advantage of iPad stations located throughout clinics. Those who choose to take part will be eligible to participate in studies planned to assess the benefits of personalized care strategies. Cardiologist and clinician-scientist, Dr. James White, MD, LPMI director and principal investigator of the PULSE Clinic program, says the program and its supporting infrastructure is one of the most ambitious programs of its kind in Canada. “By routinely asking cardiac patients across all clinic locations how they want their data used for innovation and building pathways to securely manage their data with the health authority, we have established a framework to support the implementation of personalized care, not just researching it,” says White. “This creates a unique opportunity for us to test and measure the value of personalized clinical decision-making for Albertans.” Participants will also be provided follow-up surveys every six months, allowing them to identify trends in their own health and track changes over time.
4
LIBIN LIFE
Patients can withdraw from the program at any time. Dr. Melanie King, PhD, LPMI’s associate director, says getting the project off the ground was a team effort involving many people, from health-care leaders and researchers to data specialists and patient partners. She adds patient feedback, gathered during the testing phase, has been very positive. “This is very exciting,” she says. “A lot of people worked very hard to make this project a reality, and we believe it will have an incredible impact on care for cardiac patients.” For more information about the PULSE Clinic Program, visit libin.ucalgary.ca/pulseprogram.
Expanding Precision Medicine The Libin Precision Medicine Initiative (LPMI) continues to grow beyond its initial PULSE Clinic Project implementation site, with new efforts now underway. The initiative has recently broadened to include the Women’s Cardiovascular Health Clinic. The team is continuing to expand on the digital infrastructure they have built to support precision health across all aspects of cardiovascular care and research, as well as optimizing potential to collaborate across a variety of other areas of care. Continued growth of the initiative depends on securing funding for essential needs, including specialized expertise, data storage, and ongoing research and development that will optimize opportunities for researchers and patients across the Institute and the province.
Learn more or support LPMI at libin.ucalgary.ca/initiatives/ precision-medicine-initiative
5
LIBIN LIFE
LIBIN INITIATIVES
Transforming Women’s Heart Health Through Research, Care & Collaboration A woman dies every 16 minutes in Canada from cardiovascular disease, yet women’s heart health has long been overlooked. Today, the initiative is going strong and has an ambitious vision for the future. By Dawn Smith Women's Cardiovascular Health Initiative Bridging the Gap
At its heart is a new clinic dedicated to women’s cardiovascular care, set to open under Sandhu’s leadership. The clinic, now open as a pilot program, will bring together specialists across disciplines to offer integrated, research-informed care for women and gold-standard testing previously unavailable in Southern Alberta, all while fueling new discoveries about women’s heart health. The aim is to ensure that the information generated through research translates into clinical practice. Alongside this ambitious project, the WCHI will continue to empower the community by educating individuals in Calgary and beyond about women’s unique risk factors for cardiovascular disease and by encouraging them to take an active role in improving their own heart health. “We have an opportunity to develop a national centre of excellence right here in Calgary,” says Sandhu. “This is about improving the health of women at risk of, or living with, heart disease through exceptional care, innovative research, education and community engagement.”
It’s a truth that drives the Libin Institute Women’s Cardiovascular Health Initiative (WCHI) team. “Women make up at least half of the population and yet we are under-treating and under-studying this population,” says Dr. Paul Fedak, MD, PhD, director of the Libin Institute. “Given that cardiovascular disease is a leading cause of death, that is really terrifying.” Dr. Roopinder Sandhu, MD, agrees. A clinician-scientist specializing in heart rhythm and the director of the WCHI, Sandhu is leading efforts to close the gender gap in care, research and outcomes. “There’s been this long-held misconception that women are protected from cardiovascular disease, and that’s resulted in a lack of understanding of cardiovascular disease in women, underdiagnosis and undertreatment,” she says. Much of the inequity stems from the fact that historically, most cardiovascular research focused on men, leaving women’s unique risk factors—like pregnancy and menopause—understudied. As a result, diagnosis can be delayed, symptoms misunderstood and treatments less effective for women. The WCHI, launched in 2019 as a grassroots collaboration of researchers and clinicians with diverse interests and specialties, was created to change that reality. With a shared passion for improving cardiovascular health for women, the group had numerous early successes, including receiving a Certificate of Excellence from Hypertension Canada and a University of Calgary Equity, Diversity and Inclusion award.
6
LIBIN LIFE
Your support of the Women’s Cardiovascular Health Initiative (WCHI) helps change the trajectory of women’s heart health. Every donation—large or small—makes a difference. Help the WCHI as it: • Addresses the critical evidence gaps that exist for women's cardiovascular health • Launches its new clinic • Harnesses big data and AI to improve diagnosis and treatment of cardiovascular disease impacting women • Empowers emerging leaders through scholarships and awards • Promotes visionary thinking through its think tank retreats • Fuels breakthroughs through catalyst funding • Empowers hundreds of Calgarians towards better cardiovascular health annually through its public library series, signature community events and the Libin Wears Red movement • Works to establish Canada’s first fellowship in women’s cardiovascular health Give today and help us save women’s lives by preventing and treating cardiovascular disease in a more personalized and precise way. Visit: engage.ucalgary.ca/ WomenCardiovascularHealthInitiative Every Gift Counts A meaningful gift is that which is meaningful to you
Dr. Roopinder Sandhu with a patient. Photo Credit: Riley Brandt, University of Calgary, 2025
7
LIBIN LIFE
P2 Initiative Exposing & Addressing Cardiovascular Health Inequities By Dawn Smith LIBIN INITIATIVES
I t may be comforting to believe every Canadian enjoys the same standard of health care, but the facts show otherwise. According to the Government of Canada, health inequities do indeed exist—some Canadians receive excellent care, while others face barriers tied to factors like income. The Person to Population (P2) Initiative—a flagship program of the Libin Cardiovascular Institute— is addressing this problem with a new focus: exposing and addressing cardiovascular health inequities in Alberta and beyond. “Most people in Canada have the impression that we live in a system with universal access, but when you look at the data or listen to marginalized groups you see a different story,” says P2 co-lead Dr. David Campbell, MD, PhD. “It’s quite disturbing that some people receive world-class care and others don’t.” Formed in 2016, P2 unites epidemiologists, cardiologists, data scientists, community engagement researchers and public health experts. The team has the expertise to lead nationally in cardiovascular equity research. Several P2 members already study inequities: Dr. Campbell focuses on diabetes and homelessness; others examine food insecurity, disease prevention in immigrant communities and unequal access to new medications and devices.
Campbell says members are energized by the new direction. “We have an opportunity to fill a niche in cardiovascular health inequity research in Canada,” says Campbell. “Cardiovascular health inequities are fundamentally addressable. By bringing to light and conducting research, we can make a change.” One person’s story is showing how this vision is already becoming a reality. FROM HOMELESSNESS TO HEALTH EQUITY RESEARCH Matthew Larsen’s path to becoming a researcher began in the most unlikely of places—while he was living with diabetes and experiencing homelessness. “It made everything twice as hard,” he says. That changed in 2019, when he spotted a flyer for a research study focused on people experiencing
diabetes and homelessness. Curious, he joined his first meeting of the Toronto Clients with Diabetes Action Committee (Toronto CDAC) and began working as a community co- researcher with Dr. Campbell. He was struck by how respectfully academic researchers treated participants and by the value they placed on lived experience. In 2021, Larsen and Campbell started the Calgary Diabetes Advocacy Committee (CDAC). Larsen’s role was as a peer researcher. Listening to others in the group share their stories of hardship and resilience sparked an interest in understanding why some people flourish despite immense challenges. He eventually decided to pursue a master’s degree in Community Health Sciences under Campbell’s supervision. Supported by the Libin Cardiovascular Institute’s P2 Graduate Scholarship for Cardiovascular Health Promotion, Larsen recently completed his degree. His unique research project, for which he worked closely with the CDAC, focused on how shame affects this population and how resilience can be built through supportive communities. “Being unable to control your life causes shame,” says Larsen. “The best way to overcome it is by connecting with people who understand. My goal is to empower people by giving them tools to reduce shame."
Matthew Larson
8
LIBIN LIFE
Donor support powers P2—transforming lived experience into research that drives change. Your gift helps fund: • $10K Seed Grants that unlock major research funding • Student Scholarships to train equity- focused researchers • Collaborative Retreats that spark new ideas Join the Movement From $500 prizes to $10,000 seed grants, every gift makes a difference! Find out how you can support P2’s equity mission here: Fueling Equity in Action
libin.ucalgary.ca/donate
We have an opportunity to fill a niche in cardiovascular health inequity research in Canada. " "
Dr. David Campbell and Dr. Hude Quan
9
LIBIN LIFE
CLINICAL INNOVATION SPOTLIGHT
Amyloidosis Program of Calgary a National Leader By Dawn Smith
S even years ago, family physician Dr. John Pasternak, MD, sat alone in his clinic office, staring at test results that changed everything. “I hung my head and thought, ‘now what?’” he recalls. He had just been diagnosed with cardiac amyloidosis—a rare and progressive disease that he hadn’t even known he had. He was told he had only five years to live. The news was a shock. Pasternak had only recently started experiencing symptoms of heart failure. Like many patients with amyloidosis, his condition had gone unnoticed for some time. In the months that followed, he checked off a list of bucket-list dreams—golfing at St. Andrews among them— and tried to come to terms with a shortened future. But then came a call that changed his path. “It brought tears to my eyes,” he says. Dr. Nowell Fine, MD, his amyloidosis specialist, was calling to offer him a place in a new clinical trial for Tafamidis, a drug designed to halt the progression of the disease. “Sign me up,” Pasternak replied without hesitation. Today, his condition is stable, and he is enjoying a life filled with travel, golf, family and friends. “I have a great quality of life and real hope for the future,” he says. Stories like Pasternak’s underscore the importance of timely diagnosis, access to cutting-edge treatments and coordinated care—pillars of the Libin Cardiovascular Institute’s Amyloidosis Program of Calgary (APC). Led by Libin Cardiovascular Institute member Dr. Fine, the APC was established in 2021 and has quickly become a nationally recognized leader in amyloid research, education and care. The program combines a specialized clinical service with a research hub and the country’s first dedicated amyloidosis fellowship program. “Our goal is to ensure no patient goes undiagnosed or untreated because of a lack of awareness or access,” says Fine.
Our goal is to ensure no patient goes undiagnosed or untreated because of a lack of awareness or access. " " For Pasternak, that progress is personal. He knows how different his story might have been without a timely diagnosis and access to treatment—and he’s hopeful for the next generation of patients. “Ten years ago, this outcome wouldn’t have been possible,” he says. “It has been a very positive experience to be involved with the great team in Calgary.” “None of this would be possible without the support of our patients,” says Fine. “Their participation in clinical trials and their willingness to share their perspectives are driving real progress.” Cardiac amyloidosis affects roughly 10 in every million Canadians. It occurs when abnormal protein deposits build up in the heart, leading to stiffening and heart failure. Because it mimics more common conditions, diagnosis can be delayed—something APC is working hard to change. By developing and leading initiatives like the Canadian Registry for Amyloidosis Research and the Alberta Amyloid Working Group, APC is improving how patients are diagnosed and treated. The program also helped establish the Canadian Amyloidosis Society, chaired by Fine, and launched Amyloid Day, now the Canadian Amyloidosis Summit, which is advancing education, awareness and care quality at a national level.
10
LIBIN LIFE
Members of the Amyloidosis Program of Calgary team.
Philanthropy is essential to the Amyloidosis Program of Calgary, helping drive its mission in research, education, advocacy and patient care. “Donor support allows us to fund clinical and research fellows, support graduate students, and build key resources like a national disease registry,” says Dr. Fine. “It truly expands what we’re able to accomplish.” Beyond funding, community support reinforces the importance and relevance of the program’s work. “It’s incredibly meaningful to know the community believes in what we’re doing,” he adds. With continued support, the program is poised to grow its impact and improve care for people living with amyloidosis. Find out more and give today by visiting libin.ucalgary.ca/donate Philanthropy Fuels Progress
11
LIBIN LIFE
MEET A RESEARCHER
Cracking the Genetic Code of Heart Conditions
By Dawn Smith
A t the University of Calgary’s Libin Cardiovascular Institute, world-renowned researcher, Dr. Wayne Chen, PhD, is uncovering hidden genetic causes of deadly heart conditions, paving the way for earlier diagnosis and life-saving treatments for patients and families at risk. Chen, a professor at the University of Calgary’s Cumming School of Medicine and member of the Libin Cardiovascular Institute, and his international team, have recently identified a surprising player in the genetics of cardiac arrhythmias: the ITPR1 gene. Previously known for its role in brain conditions, such as movement disorders and seizures, ITPR1 has now been linked to life-threatening heart rhythm problems, particularly under stress, such as during exercise or emotional events. These arrhythmias can lead to sudden cardiac arrest—one of the most devastating cardiac events. “This is an important first step toward reducing the risk of sudden cardiac death in patients with these mutations,” says Chen. “Now clinicians can include this gene in the screening process for diagnosing unexplained arrhythmias.” Published in Circulation , one of the world’s leading cardiovascular scientific journals, Chen’s study identified multiple mutations in ITPR1 that disrupt calcium handling in the heart’s specialized Purkinje fibers—key muscle fibers that help regulate the heartbeat. When the gene malfunctions, it can cause dangerous electrical misfires, leading to arrhythmias. A NEW TEST FOR A SILENT KILLER Chen also co-led the development of a simple, widely accessible clinical test to detect Calcium Release Deficiency Syndrome (CRDS)—a deadly inherited arrhythmia first identified by his lab at the Libin Cardiovascular Institute in 2021. Until now, CRDS was virtually invisible to standard clinical tests, often leading to tragic, unexplained
cardiac arrests. Chen’s new diagnostic method, published in JAMA, monitors for changes in electrocardiography (ECG) tests after a brief fast heartbeat followed by a pause. The test can be easily performed in many clinical settings using existing equipment. “This is an important discovery because there is an urgent need for a clinical diagnostic test for CRDS,” says Chen. “This will allow us to identify individuals at risk, better understand the prevalence of CRDS and, hopefully, develop treatments for the condition.” The study, conducted with co-lead Dr. Jason Roberts, MD, and a team spanning seven countries, represents a major step forward in saving lives. Their work is continuing through the PHRI DIAGNOSE CRDS trial, an international effort to further validate the new test in hundreds of patients worldwide. PHILANTHROPY POWERS DISCOVERY Dr. Robert Rose, PhD, acting director of the Libin Cardiovascular Institute, says these discoveries illustrate the importance of investing in fundamental research. “Wayne’s research is a perfect example of why discovery science matters,” says Rose. “It lays the groundwork for precision medicine, where we can tailor treatments to the unique genetic makeup of each patient.” Each year, approximately 60,000 cardiac arrests occur outside of hospitals in Canada and fewer than 10 per cent survive. Thanks to world-leading research at UCalgary’s LCI, made possible by the support of national funders, international partners and philanthropic donors, there is new hope for preventing these tragedies. “Ultimately, our goal is to save lives,” says Chen. “Every step toward understanding the root causes of arrhythmias brings us closer.”
12
LIBIN LIFE
Dr. Wayne Chen, PhD, in his lab at the University of Calgary's Cumming School of Medicine.
Accelerating Discovery, Saving Lives, Fueling Equity in Action
At the Libin Cardiovascular Institute, philanthropy powers progress. Generous support from the community helped purchase a $1.2-million two-photon confocal microscope, now central to groundbreaking research. This advanced imaging tool allows scientists to see deep into living tissue, enabling discoveries that were once out of reach. Dr. Wayne Chen, an international leader in arrhythmia research, is using the microscope to observe how calcium channels behave in the beating heart—work that has resulted in the discovery of a life-threatening heart rhythm disorder and diagnostic tool. Your support drives innovation and saves lives. Learn more about supporting life-saving cardiovascular research at libin.ucalgary.ca/donate
13
LIBIN LIFE
DONOR SPOTLIGHT
Honouring the Mozell Family
T he Libin Cardiovascular Institute’s rise to national and international prominence over the past 20 years has been fuelled by visionary research, clinical innovations—and the generosity of community champions like J.L. “Sam” and Beverley Mozell. They have invested more than $14.5 million to advance research, care and education initiatives at the Libin Institute since the late 1990s. Sam lived a remarkable 96 years before passing away in January. He generously left another $3 million to the Institute, ensuring the family’s legacy of helping shape cardiovascular health will last far into the future.
A legacy of generosity and impact at the Libin Cardiovascular Institute
Investigator Dr. Matthew James, MD, PhD, left, and patient-researcher Winnie Pearson. Giving back to the community gave Sam immense pleasure, his family says—especially knowing he and Beverley were making a significant impact on cardiovascular health care worldwide through their giving to the Libin Institute.
“We are deeply grateful for the Mozell family’s exceptional generosity,” says the Institute’s director, Dr. Paul Fedak, MD, PhD. “Their visionary philanthropy is saving lives and transforming care for cardiovascular patients in Alberta and beyond.” Sam’s family describes him as a natural-born entertainer who had a knack for making people laugh and made an impression on everyone he met. He and Beverley, who married in 1956, built a life and family together, with two children, several grandchildren and great-grandchildren. He enjoyed a successful 40-year career in the oil and gas industry.
By Dawn Smith & Mia Sosiak
14
LIBIN LIFE
The new planned gift will help improve women’s heart health outcomes through the Beverley Mozell Graduate Scholarship in Women’s Cardiovascular Health. It will also catalyze innovative cardiovascular research with high potential for impact, and, via the Mozell Scholar Award, fund training for the next generation of cardiovascular research leaders. The Mozells’ philanthropic journey with the Cumming School of Medicine began in 1997, when they supported international health education opportunities. In the early 2000s, they invested in genetics research and established a state-of-the-art heart rhythm lab. The J.L. “Sam” and Beverly Mozell Heart Rhythm Lab at Foothills Medical Centre “transformed treatment for atrial fibrillation and has since helped more than 5,000 patients,” Fedak says. The Mozell Family Analysis Core Lab was made possible by a gift from the family. This shared resource helps researchers analyze and interpret data. The family also helped the Institute acquire advanced imaging technologies, including a mobile ultrasound system and a two-photon confocal microscope — both essential for research into heart and vascular diseases. They supported recruitment of several top-tier talents, including Dr. James White, MD, who leads the LPMI, and Dr. Satish Raj, MD, a leader in autonomic disorders. A Mozell gift also established the D.G. Wyse Professorship, now held by Dr. Robert Rose, PhD, to advance research in cardiac arrhythmias.
Their visionary philanthropy is saving lives and transforming care for cardiovascular patients in Alberta and beyond. " "
15
LIBIN LIFE
Autonomic Lab Finding Real-World Solutions for Patients FUNDING IN ACTION By Dawn Smith
D arla Bennett’s life took an unexpected turn after contracting COVID-19 in December 2021.
One of Bennett’s symptoms is chest pain, which can feel like a stab or ache and worsens when she is fatigued. She recently took part in a study in the Autonomic Lab that is investigating the cause of chest pain in POTS patients. Led by PhD student Kavithra Karalasingham, the study examines whether chest pain in POTS patients may be linked to microvascular angina—reduced blood flow in the heart’s small vessels. Karalasingham’s novel work combines research in the Autonomic Lab with the advanced tools and technologies found in another Libin Institute resource, the Stephenson Cardiac Imaging Centre. Founded in 2005 thanks to a visionary donation from Calgary philanthropist Ken Stephenson, the Stephenson Centre is not only one of the busiest cardiac MRI centres in North America, but it’s also an internationally respected research powerhouse. Study participants, like Bennett, visited the Stephenson Centre
several times to receive scans after being given a stress-inducing medication, both while in a lower- body vacuum chamber to simulate standing and with MRI-contrast to detect scarring or inflammation. Karalasingham compared results to imaging taken at rest and on the tilt table found in the Autonomic Lab. Karalasingham, who is inspired by the patients she meets and interacts with, says its important to understand the cause of the chest pain in POTS patients. “Although POTS causes an increase in heart rate, it isn’t always associated with heart conditions,” she says. “It’s important to understand if a patient’s cardiac function changes when they are symptomatic.” Karalasingham’s supervisor, Dr. Raj, agrees, adding the chest pain these patients endure can be quite severe and can limit their ability to take part in activities. “Between 40-50 per cent of POTS patients have chest pain, and we don’t know what is causing
Long after the initial infection, she continued to experience persistent fatigue, a racing heart, exercise intolerance and a purplish discoloration in her hands and feet." “It just didn’t seem to go away, and I realized something was wrong,” says the mom of three. Two years later, Bennett was diagnosed with Long-Covid POTS (postural orthostatic tachycardia syndrome), an autonomic condition characterized by a rapid heartbeat upon standing, which leaves patients feeling lightheaded and often short of breath. Bennett’s early diagnosis was possible, in part, to donors who provided support to purchase the specialized equipment found in the Libin Institute’s Autonomic Lab, headed by Dr. Satish Raj, MD. It’s one of the few centres in Canada that detects and researches complex autonomic conditions like POTS.
"
Donor funds are critical for my research and critical for the Institute.
"
16
LIBIN LIFE
it,” says Raj, adding it could be an issue with their pain sensing system, microvascular problems or atherosclerosis (plaque build up). “It’s hard to treat a problem when we don’t know the cause of it.” The Autonomic Lab is dedicated to finding real-world solutions for patients living with complex autonomic conditions, including POTS. According to Raj, this vital work relies heavily on donor funding. Thanks to philanthropic support, the lab recently acquired a new tilt table—a crucial tool used to diagnose and study these often-misunderstood conditions. “Donor funds are critical for my research and critical for the institute,” says Raj. “Philanthropy helps support scholarships, research and seed grants that generate the data we need to compete for major national funding.” Your support fuels discoveries that change lives.
Dr. Satish Raj and Kavithra Karalasingham with a patient. Photo credit: Britton Leddingham, iEvolve Media
17
LIBIN LIFE
FUNDING IN ACTION
Seed Funding Sparks Top-Ranked Heart Research
By Dawn Smith
Dr. Vaibhav Patel, PhD, in his lab at the University of Calgary's Cumming School of Medicine.
If we can understand what factors are driving or stopping this healing response, we can use that information to develop personalized therapies to improve outcomes after heart attacks. " " LIBIN LIFE
18
Philanthropy propels cardiovascular discovery
A generous gift. A bold idea. And a top-ranking grant. That’s the trajectory of a University of Calgary research project that’s helping us understand the heart’s potential to heal. In 2023, a team of multidisciplinary researchers at the Libin Cardiovascular Institute received inaugural support from the Michael and Terry Wilson Cardiovascular Research Innovation Fund. Their mission was to investigate the role of epicardial adipose tissue (EAT)—the fatty tissue that surrounds the heart—in driving or protecting against cardiovascular disease. Now, some members of that team have leveraged early-stage philanthropic support into more success. Researchers Dr. Vaibhav Patel, PhD, and Dr. Paul Fedak, MD, PhD, secured a highly competitive Canadian Institutes of Health Research (CIHR) Project Grant, ranking first in the pan-Canadian competition. “It’s a powerful example of how philanthropy accelerates science,” says Fedak, Libin Institute director. “The Wilson funding allowed us to generate the critical early data we needed to show the potential of this new area of research. We’re now building on that foundation to explore therapies that could truly change lives.” A NOVEL FRONTIER IN HEART HEALTH While cardiovascular disease remains the leading cause of premature death
worldwide, EAT has emerged as a potential key player. This fat tissue, once thought to be biologically inert, is now being recognized for its active role in inflammation, scarring and cellular signaling that may influence heart and vascular conditions like atrial fibrillation and post-heart attack healing. With the Wilson funding, Patel and a diverse team of scientists and clinicians began deciphering the molecular crosstalk between EAT and the heart— how signals from this tissue might spark or suppress disease processes. That research opened the door to a new and intriguing hypothesis: that stem cells found within EAT could help the heart heal after a heart attack. UNLOCKING THE HEART’S HEALING POTENTIAL Backed by the CIHR grant, Patel and Fedak are now looking deeper to understand the mechanisms behind how EAT-derived stem cells might stimulate the repair of damaged heart tissue. Exciting early data from Patel’s lab suggests these stem cells do have cardioprotective properties—but that function is impaired in people with Type 2 diabetes, a group at especially high risk for heart complications. “We are looking at finding the magic factor that’s cardioprotective,” says Patel. “If we can understand what factors are driving or stopping this healing response, we can use that information to develop personalized therapies to
improve outcomes after heart attacks.” Samples from local cardiac surgery patients, collected as part of Fedak’s translational research program, are being used in conjunction with animal models to test these theories. It’s an approach made possible through strong collaboration. FROM SEED TO SUCCESS For both Patel and Fedak, this work underscores the immense value of early-stage, donor-driven funding in catalyzing discovery. The Michael and Terry Wilson Cardiovascular Research Innovation Fund was specifically created to support high-risk, high-reward ideas—projects that may not yet be ready for large- scale grant competitions but hold extraordinary potential. “The Michael and Terry Wilson gift came at the right time,” says Fedak. “Without it, we wouldn’t have been able to generate the preliminary data that helped us secure the CIHR funding. That support was critical.” As this groundbreaking research continues, the Libin Cardiovascular Institute remains committed to fostering innovation that can improve heart health in Calgary and beyond. And behind many of these innovations are visionary donors who believe in the science—and the people—working to push it forward. “We’re incredibly grateful,” says Patel.
19
LIBIN LIFE
CORE LAB SPOTLIGHT
Physiology Core Lab Fuels Cardiovascular Research
By Dawn Smith
D r. Darrell Belke, PhD, way through a run, puzzling over how the body temperature of hibernating gophers impacted the movement of calcium in the animals’ heart cells. It was a question he’d been chasing for months while completing his master’s degree in Zoology at the University of Alberta. And then, clarity. remembers the moment inspiration struck. He was part “I had a true eureka moment,” he says with a smile. “Everything just clicked.” That spark of insight into how the heart of gophers can adapt to extreme conditions increased our understanding of heart disease, a condition in which the heart doesn’t function normally. It was the start of a new chapter in the northern Alberta farm kid’s journey. Belke’s curiosity inspired him to continue his scientific career. He completed his PhD in pharmacology at the University of Alberta and a postdoctoral fellowship in pharmacology and physiology at the University of Calgary. The latter work resulted in the development of the first working mouse heart model used in the study of energy metabolism, a model now used in laboratories around the world. Belke’s education continued with a second postdoctoral fellowship in molecular biology—this time at the
University of California at San Diego. Afterwards, he took on the role of project scientist at the institution, where he remained for a decade. He returned to UCalgary in 2009 to take over the lab of his former mentor, David Severson, PhD, in the Heritage Research building. The lab focused on the regulation of cardiac metabolism and the effects of diabetes on heart health. Over the years, Belke gained a broad range of technical expertise—from building and modifying equipment, to molecular imaging and microsurgery on mice—thanks to the mentorship and collaboration he’s experienced throughout his research career. Today, those skills are used at the Libin Institute, where he leads the Cardiovascular Physiology Core Lab, helping fellow scientists advance their own discoveries. The lab provides vital infrastructure for cardiovascular research, offering services such as small animal surgery, high-resolution echocardiography, pressure-volume loop analysis and the development of custom animal models that mimic heart disease. “Our job is to help move research forward,” says Belke. “We generate the measurable data scientists need using non-invasive imaging and precise surgical models that simulate heart attacks, high blood pressure, aneurysms and more.” Whether it’s coronary artery ligation to assess heart attack damage or
Doppler echocardiography to analyze mitral valve function, the lab gives researchers the ability to visualize and quantify subtle cardiac changes—even in structures as small as a mouse coronary artery. The core lab’s impact is far reaching. Belke not only enables other scientists to test hypotheses, validate therapies and publish data, but he also teaches the next generation of scientists the skills they need to pursue careers. Belke’s gopher chasing days may be long behind him, but as he speaks about his work in the Cardiovascular Physiology Core Lab, his passion for research and collaboration is obvious. “I love what I do,” he says. “I get to contribute to a wide variety of research projects across the Libin Cardiovascular Institute. For me, it’s about the thrill of discovery.”
Our job is to help move research forward "
"
20
LIBIN LIFE
Dr. Darrell Belke, PhD, in his lab at the University of Calgary's Cumming School of Medicine.
Impact at a Glance
The Cardiovascular Physiology Core facility continuously contributes to the publications of our members, including high impact journals like Circulation, Circulation Research, PNAS, Immunity and Science Translational Medicine.
Belke provides our members with integral supports for grant applications, including at such funding agencies as the Canadian Institutes of Health Research, the National Institute of Health and the Heart and Stroke Foundation.
The lab contributes to the education of dozens of graduate students and lab staff each year through mentorship and training on skills like open chest surgeries, isolating individual cardiac myocytes and capturing and interpreting pressure-volume loops.
The lab advances science beyond cardiovascular health. Belke works with researchers from numerous health research institutes at the University of Calgary, including in the Faculty of Veterinary Research.
21
LIBIN LIFE
CORE LAB SPOTLIGHT
Core Pathology Lab Supporting Critical Research Projects
By Dawn Smith
D r. Yong-Xiang Chen, MD, PhD, has a very proud family. Growing up in China during the Great Proletarian Cultural Revolution (GPCR), it was difficult to imagine Chen would have such a successful life, but his curiosity, dedication and hard work paid off. “Growing up, my family was very poor,” says Chen. “My father and mother didn’t have an education, they couldn’t read or write, and they worked as labourers in a train-maker factory in Changchun, China. My brother was sent to the countryside to work and wasn’t able to attend university.” Fortunately for Chen, China’s policies changed after the GPCR ended in October of 1976 and the young man was able to enrol in medical school in 1978. “At that time, my father worked in a factory and put up a list of the names of employees’ children who were in university. My father was very proud that my name was on that list,” reflects Chen. In 1983, Chen graduated with his medical degree from the Norman Bethune Medical College in Changchun, China and began working as a physician specializing in cardiovascular disease. After 10 years in this role, Chen’s curiosity led him to a career change. “I wanted to understand the reasons behind disease, so I entered the Kyushu University Faculty of Medicine at the Graduate School of Medical Sciences in Japan,” says Chen. Chen completed his PhD in pathology at age 40 and moved to Canada to pursue a postdoctoral fellowship. His postdoc supervisor was Dr. Ed O’Brien, MD, a former member of the Libin Cardiovascular Institute. When O’Brien was recruited to Calgary in 2013, Chen followed. He now manages the Core Pathology
Laboratory at the Libin Cardiovascular Institute. It’s a role he relishes. “I enjoy working with many different labs on their projects,” says Chen. “I am happy to be using my knowledge and advancing science.” The lab, located at UCalgary’s Foothills campus, is a shared resource centre that manages and processes human and animal tissue and artificial samples. All University of Calgary principal investigators, as well as their staff and students, can take advantage of the services, which include processing tissue blocks and using chemical stains, histopathology diagnosis and analysis. It’s an important service that helps bridge the gap between basic science and clinical questions. “If you work with animal models, you need core pathology,” says Chen, explaining pathology, which involves studying the causes, nature and effects of diseases with a focus on how diseases impact tissues and organs at a cellular level, is critical for research. Chen also spends time training technicians and students on techniques and how to use the powerful imaging equipment found within the lab. He has supported projects on everything from examining the impacts of using animal models to looking at human diseases, particularly in the cardiovascular field. Chen does it all with a smile because he has found immense happiness in his work. “Do what you want to do but make it something that helps other people and society,” he advises. “Have experiences, look at different cultures, and, finally, work hard. If you are happy, you will have the energy to do what you should do.”
22
LIBIN LIFE
Dr. Yong-Xiang Chen , MD, PhD, in his lab at the University of Calgary's Cumming School of Medicine.
About the Core Pathology Lab
Supports peer-reviewed publications
Collaborates with researchers across numerous disciplines, including those focusing on cardiovascular, cancer, neuroscience, psychology and chronic disease fields
Contributes to research from the Libin, Snyder and Arnie Charbonneau Cancer institutes, and the Cumming School of Medicine
23
LIBIN LIFE
TRAINING THE NEXT GENERATION
Trainee Organization Building
Community
By Dawn Smith
T he Libin Cardiovascular Trainee Organization (LCITO) brings together the Institute’s graduate students with the aim of improving their educational experience. Developed three years ago by student leaders, the LCITO is helping create a community amongst Libin
trainees working on their masters, PhDs, postdocs and clinical training programs. “It’s fun to be part of the LCITO,” says Jessica Wager, who served as the group’s president for the 2023-24 and 2024-25 school years. “It’s important for building community amongst trainees who tend to become
Members of the 2023-2024 LCITO Executive Team.
"
It’s important to have a student voice within the greater Libin community.
"
24
LIBIN LIFE
Investing in the Next Generation of Heart Health Leaders The Libin Cardiovascular Trainee Organization (LCITO) is driven by passionate graduate students who volunteer their time to build community, foster collaboration, and grow as future leaders in cardiovascular research and care. With limited resources, LCITO organizes professional development events, hosts student-led research days, and ensures trainees have a voice within the Institute. Your support can help LCITO expand its efforts— helping empower students to thrive in and beyond the lab. Consider supporting the future of cardiovascular research by investing in our trainees.
isolated working in smaller labs located in different areas of the campus.” The LCITO is comprised of student volunteers. They organize educational, career development and social events, ranging from journal clubs to an annual meet and greet to career development sessions, on a limited budget. The group also hosts a summer student research day, takes part in planning the Libin Institute’s annual Tine Haworth Research Day and acts as a student spokesperson within the Institute. Wager, a doctoral student in the basic science lab of Dr. Jennifer Thompson, PhD, says the group has helped her feel like part of the Libin community. “Grad school has a lot of ups and downs, so it’s nice for people to connect with others going through the same things,” says Wager. “Networking with others and finding things in common might also help you with your research.” Carmina Albertine Isidoro, who is pursuing her PhD in the basic science lab of Dr. Justin Deniset, PhD, has served on the LCITO for two years, and is the new president. She says the LCITO not only helps create a community, but members of the group learn a lot of skills, such as leadership, time management, event organization and meeting management, that are likely to be useful in future careers. Isidoro enjoys being part of the LCITO team and notes she got involved to be an advocate for her student colleagues. “It’s important to have a student voice within the greater Libin community,” she says.
Learn more at libin.ucalgary.ca/donate
25
LIBIN LIFE
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32Made with FlippingBook - professional solution for displaying marketing and sales documents online